Dr. Ajuah O. Davis, MD is a pediatric endocrinologist in Cleveland, OH specializing in pediatric endocrinology. She graduated from Northwestern University, Feinberg School of Medicine. Dr. Ajuah O. Davis, MD is affiliated with MetroHealth.
Dr. Ajuah O. Davis, MD graduated from Northwestern University, Feinberg School of Medicine. She completed residency at University of Chicago Medical Center. She has a state license in Ohio.
Medical School: Northwestern University, Feinberg School of Medicine
Residency: University of Chicago Medical Center
Licensed In: Ohio
Dr. Ajuah O. Davis, MD has an exceptional overall rating with an average of 4.82 out of 5 stars based on 34 ratings. We collect ratings and reviews of Dr. Ajuah O. Davis, MD from all over the web to help you find the right in Cleveland, OH.
These charts describe general payments received by Dr. Ajuah O. Davis, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
| INSULET CORPORATION |
$243
Omnipod $243 |
||
|---|---|---|---|
| Abbott Laboratories |
$200
FreeStyle Lite system $200 |
||
| BETA BIONICS, INC. |
$172
iLet Insulin Infusion Kit Contact Detach $172 |
||
| Dexcom, Inc. |
$125
DEXCOM G7 GSS (161) $125 |
||
| TOLMAR, INC. |
$24
FENSOLVI $24 |
||
| Other |
$49
VOXZOGO 1.2mg $20 |
SUPPRELIN $15 |
t:slim X2 Insulin Pump with Control-IQ $14 |
| Food and Beverage | $589 |
|---|---|
| Education | $224 |
Dr. Ajuah Davis is a specialist in pediatric endocrinology. These areas are among her clinical interests: gastrointestinal surgery, endocrine diseases (hormone disorders), and endoscopic surgery. Patient reviews placed her at an average of 5.0 stars (out of 5). Dr. Davis is a graduate of Northwestern University, Feinberg School of Medicine. Dr. Davis's training includes a residency program at the University of Chicago Medical Center. Dr. Davis (or staff) is conversant in Spanish and French. She is professionally affiliated with MetroHealth. Her practice in Middleburg Heights, OH is open to new patients as reported by MetroHealth.